AIMS: To test the non-inferiority of a single dose of tadalafil 20 mg compared with placebo with respect to 26-h mean ambulatory systolic and diastolic blood pressure in treated and untreated hypertensive subjects. METHODS: A multicentre, randomized, double-blind, placebo-controlled crossover study in 114 subjects with hypertension (36 subjects on no therapy with daytime mean ambulatory blood pressure >/= 140/85mmHg; 38 subjects on two to four classes of antihypertensive agents with daytime mean ambulatory blood pressure >/=140/85 mmHg and 40 subjects on two to four classes of antihypertensive agents with ambulatory blood pressure < 140/85 mmHg). RESULTS: Overall tadalafil reduced mean ambulatory blood pressure monitor systolic and diastolic blood pressure by 4.8 mmHg [95% confidence interval (Cl) 3.7, 5.9; P < 0.01] and 2.9 mmHg (95% CI 1.9, 3.6; P < 0.01), respectively, compared with placebo. In hypertensive subjects with uncontrolled blood pressure on two to four classes of antihypertensive agents (n = 36) tadalafil reduced mean ABPM systolic and diastolic blood pressure by 7.5 mmHg (95% CI 5.4, 9.6; P < 0.01) and 4.3 mmHg (95% CI 6.1, 8.9; P < 0.01) compared with placebo. CONCLUSIONS: In patients with uncontrolled hypertension on multiple agents the addition of tadalafil 20 mg lowered mean 26-h blood pressure.
RCT Entities:
AIMS: To test the non-inferiority of a single dose of tadalafil 20 mg compared with placebo with respect to 26-h mean ambulatory systolic and diastolic blood pressure in treated and untreated hypertensive subjects. METHODS: A multicentre, randomized, double-blind, placebo-controlled crossover study in 114 subjects with hypertension (36 subjects on no therapy with daytime mean ambulatory blood pressure >/= 140/85 mmHg; 38 subjects on two to four classes of antihypertensive agents with daytime mean ambulatory blood pressure >/=140/85 mmHg and 40 subjects on two to four classes of antihypertensive agents with ambulatory blood pressure < 140/85 mmHg). RESULTS: Overall tadalafil reduced mean ambulatory blood pressure monitor systolic and diastolic blood pressure by 4.8 mmHg [95% confidence interval (Cl) 3.7, 5.9; P < 0.01] and 2.9 mmHg (95% CI 1.9, 3.6; P < 0.01), respectively, compared with placebo. In hypertensive subjects with uncontrolled blood pressure on two to four classes of antihypertensive agents (n = 36) tadalafil reduced mean ABPM systolic and diastolic blood pressure by 7.5 mmHg (95% CI 5.4, 9.6; P < 0.01) and 4.3 mmHg (95% CI 6.1, 8.9; P < 0.01) compared with placebo. CONCLUSIONS: In patients with uncontrolled hypertension on multiple agents the addition of tadalafil 20 mg lowered mean 26-h blood pressure.
Authors: Vincenzo Mirone; Pierre Costa; Jan-Erik Damber; Simon Holmes; Ignacio Moncada; Hermann Van Ahlen; Eric Wespes; William H Cordell; Melanie Chan; Danilo Lembo; Lucio Varanese Journal: Eur Urol Date: 2005-03-09 Impact factor: 20.096
Authors: C G McMahon; B G A Stuckey; D W Lording; G A Wittert; A Murphy; J Shin; P D Sutherland; N R Palmer; M P Lowy; D R Jesudason; P Fredlund Journal: Int J Clin Pract Date: 2005-02 Impact factor: 2.503
Authors: Bryan Williams; Neil R Poulter; Morris J Brown; Mark Davis; Gordon T McInnes; John F Potter; Peter S Sever; Simon McG Thom Journal: BMJ Date: 2004-03-13
Authors: F Montorsi; B Verheyden; E Meuleman; K-P Jünemann; I Moncada; L Valiquette; A Casabé; C Pacheco; J Denne; J Knight; S Segal; V S Watkins Journal: Eur Urol Date: 2004-03 Impact factor: 20.096
Authors: Robert A Kloner; Graham Jackson; Jeffrey T Emmick; Malcolm I Mitchell; Alun Bedding; Margaret R Warner; Alvaro Pereira Journal: J Urol Date: 2004-11 Impact factor: 7.450
Authors: Bradley A Maron; Gaurav Choudhary; Rebekah L Goldstein; Eric Garshick; Matthew Jankowich; Troo J S Tucker; Kathleen A LaCerda; Brack Hattler; Edward C Dempsey; Ruxana T Sadikot; Shelley Shapiro; Sharon I Rounds; Ronald H Goldstein Journal: Pulm Circ Date: 2022-03-14 Impact factor: 2.886
Authors: Ajay Nehra; Graham Jackson; Martin Miner; Kevin L Billups; Arthur L Burnett; Jacques Buvat; Culley C Carson; Glenn R Cunningham; Peter Ganz; Irwin Goldstein; Andre T Guay; Geoff Hackett; Robert A Kloner; John Kostis; Piero Montorsi; Melinda Ramsey; Raymond Rosen; Richard Sadovsky; Allen D Seftel; Ridwan Shabsigh; Charalambos Vlachopoulos; Frederick C W Wu Journal: Mayo Clin Proc Date: 2012-08 Impact factor: 7.616
Authors: Robert A Kloner; John B Kostis; Thomas P McGraw; Chunfu Qiu; Alankar Gupta Journal: J Clin Hypertens (Greenwich) Date: 2022-01-31 Impact factor: 2.885